Sykehuset I Vestfold HF

At Sykehuset I Vestfold HF, clinical research in digestive system diseases and immune system diseases focuses on ulcerative colitis and related inflammatory bowel conditions. These studies are designed to test new treatment options and better control long-term symptoms in people living with chronic intestinal inflammation.

• Improving remission and maintenance care in ulcerative colitis
• Evaluating therapies that target persistent inflammation in the gut
• Assessing symptom relief and quality of life for patients with chronic digestive disease

The site’s work in this area reflects a strong interest in advancing more effective and patient-friendly approaches for inflammatory bowel disease.

Research in neoplasms at this hospital covers several cancers, including urothelial carcinoma, prostate cancer, lung cancer, and follicular lymphoma. The trials are mainly aimed at testing new anti-cancer treatments, improving outcomes after standard therapy, and exploring precision medicine approaches for advanced disease.

• Studying treatment options for metastatic urothelial cancer and recurrent bladder cancer
• Evaluating new strategies for multiple myeloma, lymphoma, and other blood cancers
• Exploring targeted therapies for patients with advanced malignancy

This research area includes efforts to match treatment more closely to tumor biology, with the goal of improving response and delaying disease progression.

Clinical trials in hemic and lymphatic diseases are a major focus at the site, especially for multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia, and small lymphocytic lymphoma. The studies are intended to compare newer treatment combinations, improve disease control, and support deeper and longer-lasting remissions.

• Testing new therapies for relapsed or newly diagnosed multiple myeloma
• Assessing treatment options for CLL and SLL
• Evaluating care for anemia and lower-risk MDS

These trials highlight a broad hematology program aimed at improving survival, reducing transfusion needs, and strengthening long-term disease control.

Research in nervous system diseases includes studies in amyotrophic lateral sclerosis and acute ischemic stroke. The main purpose is to evaluate whether new treatments can slow neurological decline or improve recovery when time is critical after a stroke.

• Testing treatments for ALS that may slow progression
• Studying ways to improve early recovery after acute ischemic stroke
• Comparing approaches for stroke patients with complex treatment needs

This area shows the site’s involvement in both long-term neurodegenerative disease research and urgent hospital-based stroke care.

The site is also active in respiratory tract diseases and virus diseases, with studies involving chronic obstructive pulmonary disease and COVID-19. These trials aim to reduce flare-ups, improve symptom control, and strengthen antiviral treatment strategies in vulnerable patients.

• Evaluating new options for COPD with frequent exacerbations
• Studying treatment strategies for COVID-19 in immunocompromised patients
• Assessing whether updated therapies can improve respiratory outcomes

Work in this area combines chronic lung disease management with infectious disease research, reflecting a practical focus on real-world patient needs.

Clinical research in mental disorders and psychological phenomena includes studies on major depressive disorder and substance dependence involving amphetamines, benzodiazepines, and opioids. The trials are designed to improve symptom control, support recovery, and test better ways to manage dependence and treatment-resistant depression.

• Evaluating new approaches for treatment-resistant depression
• Studying care strategies for substance dependence and withdrawal management
• Assessing whether structured treatment can reduce illicit drug use

This field combines mental health and addiction research, with a strong focus on practical treatments that may improve daily functioning and long-term outcomes.

Across cardiovascular diseases, eye diseases, and other urgent conditions, the site is involved in trials for central retinal artery occlusion and stroke-related care. These studies are aimed at improving emergency treatment and exploring whether faster intervention can preserve function and reduce disability.

• Testing emergency treatment for central retinal artery occlusion
• Evaluating treatment approaches for stroke in patients with specific medication histories
• Studying time-sensitive care to improve recovery after vascular events

These projects show a focus on rapid-response medicine, where early treatment may make a major difference in patient outcomes.

Additional research at the medical department includes hormonal diseases, kidney-related conditions, and symptom-focused care after surgery. Trials involve primary adrenal insufficiency, IgA nephropathy, and low anterior resection syndrome, with the goal of improving day-to-day health, controlling disease activity, and easing ongoing symptoms.

• Studying improved hormone replacement for adrenal insufficiency
• Evaluating treatment for IgA nephropathy and protein loss in the urine
• Assessing symptom relief in low anterior resection syndrome

This part of the portfolio highlights care that goes beyond disease treatment alone, including quality-of-life and symptom management research.